PMC:7200337 / 83523-83746
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T482 | 52-60 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2760 | 31-39 | Species | denotes | patients | Tax:9606 |
| 2761 | 89-97 | Species | denotes | patients | Tax:9606 |
| 2766 | 113-116 | Chemical | denotes | HCQ | MESH:D006886 |
| 2770 | 52-60 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T475 | 0-223 | Sentence | denotes | An ongoing double-blind RCT of patients with severe COVID-19 (NCT04323527) randomized 81 patients into high-dose HCQ (600 mg 2× per day for 10 days) or low-dose (450 mg/day for 5 days) treatment groups (Borba et al., 2020). |